Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring

JACC: Heart Failure

Volumn 4, Issue 5, 2016, Pages 333-344

  Costanzo, Maria R ^a   Stevenson, Lynne W ^b   Adamson, Philip B ^c   Desai, Akshay S ^b   Heywood, J Thomas ^d   Bourge, Robert C ^e   Bauman, Jordan ^c   Abraham, William T ^f  

^a Advocate Heart Institute   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Research and Development   (United States)

^d SCRIPPS CLINIC   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f OHIO STATE UNIVERSITY   (United States)

Author keywords

Heart failure; Hemodynamic monitoring; Hospitalization; Pulmonary artery pressure

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HORMONE ANTAGONIST; HYDRALAZINE; LOOP DIURETIC AGENT; NITRIC ACID DERIVATIVE; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT; MINERALOCORTICOID ANTAGONIST;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART VENTRICLE FILLING; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; MICROELECTROMECHANICAL SYSTEM; MIDDLE AGED; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; WIRELESS HEMODYNAMIC MONITORING SYSTEM; AGED; ALGORITHM; BLOOD PRESSURE; PATHOPHYSIOLOGY; PULMONARY ARTERY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADRENERGIC BETA-ANTAGONISTS; AGED; ALGORITHMS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DIURETICS; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PULMONARY ARTERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SINGLE-BLIND METHOD; VASODILATOR AGENTS;

EID: 84964766138     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2015.11.011     Document Type: Article

References (32)

1. Drazner M.H., Rame J.E., Stevenson L.W., et al. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001, 345:574-581.
2. Setoguchi S., Stevenson L.W., Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 2007, 154:260-266.
3. Zile M.R., Bennett T.D., St.John Sutton M., et al. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 2008, 118:1433-1441.
4. Abraham W.T., Stough W.G., Piña I.L., et al. Trials of implantable monitoring devices in heart failure: which design is optimal?. Nat Rev Cardiol 2014, 11:576-585.
5. Stevenson L.W., Zile M., Bennett T.D., et al. Chronic ambulatory intracardiac pressures and future heart failure events. Circ Heart Fail 2010, 3:580-587.
6. Bourge R.C., Abraham W.T., Adamson P.B., et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 2008, 51:1073-1079.
7. Adamson P.B., Abraham W.T., Aaron M., et al. CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Card Fail 2011, 17:3-10.
8. Abraham W.T., Adamson P.B., Bourge R.C., et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011, 377:658-666.
9. Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013, 62:e147-e239.
10. Castro P.F., Concepción R., Bourge R.C., et al. A wireless pressure sensor for monitoring pulmonary artery pressure in advanced heart failure: initial experience. J Heart Lung Transplant 2007, 26:85-88.
11. Verdejo H.E., Castro P.F., Concepción R., et al. Comparison of a radiofrequency-based wireless pressure sensor to Swan-Ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure. J Am Coll Cardiol 2007, 50:2375-2382.
12. Abraham W.T., Adamson P.B., Hasan A., et al. Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure. Am Heart J 2011, 161:558-566.
13. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
14. Cameron A.C., Trivedi P.K. Regression analysis of count data 1998, Cambridge University Press.
15. Lucas C., Johnson W., Hamilton M.A., et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 2000, 140:840-847.
16. Felker G.M., Lee K.L., Bull D.A., et al. Diuretic Strategies in patients with acute decompensated heart failure. N Engl J Med 2011, 364:797-805.
17. Cuffe M.S., Califf R.M., Adams K.F., et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002, 287:1541-1547.
18. Abraham W.T., Compton S., Haas G., et al. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest Heart Fail 2011, 17:51-55.
19. Ritzema J., Troughton R., Melton I., et al. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation 2010, 121:1086-1095.
20. Konstam M.A., Gheorghiade M., Burnett J.C., et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcomes Trial. JAMA 2007, 297:1319-1331.
21. O'Connor C.M., Starling R.C., Hernandez A.F., et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011, 365:32-43.
22. Chen H.H., Anstrom K.J., Givertz M.M., et al. Low dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA 2013, 310:2533-2543.
23. Shah M.R., Flavell C.M., Weintraub J.R., et al. Intensity and focus of heart failure disease management after hospital discharge. Am Heart J 2005, 149:715-721.
24. Chaudry S.I., Mattera J.A., Curtis J.P., et al. Telemonitoring in patients with heart failure. N Engl J Med 2010, 363:2301-2309.
25. Chaudhry S.I., Wang Y., Concato J., et al. Patterns of weight change preceding hospitalization for heart failure. Circulation 2007, 116:1549-1554.
26. Desai A.S., Stevenson L.W. Connecting the circle from home to heart failure disease management. N Engl J Med 2010, 363:2364-2367.
27. Elkayam U. Nitrates in the treatment of congestive heart failure. Am J Cardiol 1996, 77:41C-51C.
28. Gogia H., Mehra A., Parikh S., et al. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. J Am Coll Cardiol 1995, 26:1575-1580.
29. Xin W., Lin Z., Mi S. Does B-type natriuretic peptide-guided therapy improve outcomes in patients with chronic heart failure? A systematic review and metaanalysis of randomized controlled trials. Heart Fail Rev 2015, 20:69-80.
30. Palardy M., Stevenson L.W., Tasissa G., et al. Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial. Circ Heart Fail 2009, 2:181-188.
31. Drazner M.H., Velez-Martinez M., Ayers C.R., et al. Relationship of right- to left-sided ventricular filling pressures in advanced heart failure: insights from the ESCAPE trial. Circ Heart Fail 2013, 6:264-270.
32. Krahnke J.S., Abraham W.T., Adamson P.B., et al. Heart Failure and respiratory hospitalizations are reduced in heart failure subjects with chronic obstructive pulmonary disease using an implantable pulmonary artery pressure monitoring device. J Card Fail 2015, 21:240-249.